Distribution of patient, tumour and treatment characteristics in women with HER2-positive, early invasive breast cancer, diagnosed in NHS trusts in England between January 2014 and December 2019 and receiving adjuvant trastuzumab-based treatment, overall and by age at diagnosis. The gene discussed is ERBB2; the disease is invasive breast carcinoma.